{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:42:35Z","timestamp":1790203355031,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00347-009-1959-4","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T13:34:15Z","timestamp":1254749655000},"page":"775-782","source":"Crossref","is-referenced-by-count":3,"title":["Eigenerhebung der Leseleistung mit dem ACTO-Selbsttest bei AMD-Patienten nach intravitrealen Injektionen","Visual self-assessment with the ACTO test during follow-up of AMD patients after intravitreal injections"],"prefix":"10.1007","volume":"106","author":[{"given":"A.","family":"Cordes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,20]]},"reference":[{"key":"1959_CR1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2008-1027918","volume":"226","author":"Antal","year":"2009","unstructured":"Antal S, J\u00fcrgens C, Grossjohann R, Tost FH (2009) Diurnal variation of ocular pressure in open-angle glaucoma with telemonitoring. Klin Monatsbl Augenheilkd 226:168\u2013175","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR2","first-page":"174","volume":"92","author":"Bach","year":"1995","unstructured":"Bach M (1995) Der Freiburger Visustest. Automatisierte Sehsch\u00e4rfenbestimmung. Ophthalmologe 92:174\u2013178","journal-title":"Ophthalmologe"},{"key":"1959_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(02)01825-1","volume":"135","author":"Beck","year":"2003","unstructured":"Beck RW, Moke PS, Turpin AH et al (2003) A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 135:194\u2013205","journal-title":"Am J Ophthalmol"},{"key":"1959_CR4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","volume":"114","author":"Boyer","year":"2007","unstructured":"Boyer DS, Antoszyk AN, Awh CC et al (2007) Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114:246\u2013252","journal-title":"Ophthalmology"},{"key":"1959_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"Brown","year":"2009","unstructured":"Brown DM, Michels M, Kaiser PK et al (2009): Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 116(1):57\u201365","journal-title":"Ophthalmology"},{"key":"1959_CR6","doi-asserted-by":"crossref","first-page":"aA9","DOI":"10.1055\/s-2008-1034937","volume":"213","author":"Draeger","year":"1998","unstructured":"Draeger J (1998) Intraocular pressure self-monitoring in glaucoma patients. Klin Monatsbl Augenheilkd 213:aA9","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","volume":"148","author":"Flynn","year":"2009","unstructured":"Flynn HW Jr, Esquiabro M (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148:43\u201358.e1","journal-title":"Am J Ophthalmol"},{"key":"1959_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00347-008-1901-1","volume":"106","author":"Hassenstein","year":"2009","unstructured":"Hassenstein A, Spital G, Scholz F et al (2009) Optical coherence tomography for macula diagnostics. Review of methods and standardized application concentrating on diagnostic and therapy control of age-related macula degeneration. Ophthalmologe 106:116\u2013126","journal-title":"Ophthalmologe"},{"key":"1959_CR9","unstructured":"http:\/\/acto.de\/media\/selbstuntersuchung\/20ACTO.swf"},{"key":"1959_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2008-1050911","volume":"186","author":"Huber","year":"1985","unstructured":"Huber C (1985) Sehprogramm f\u00fcr Augen\u00e4rzte auf Apple II, IIe and IIc Computer. Klin Monatsbl Augenheilkd 186:227\u2013230","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0028-1109407","volume":"226","author":"J\u00fcrgens","year":"2009","unstructured":"J\u00fcrgens C, Grossjohann R, Meiering J et al (2009) Home-monitoring in ophthalmology--prerequisites for an improvement in quality of life: conclusions from the management research study Teletonometry Mecklenburg-Vorpommern. Klin Monatsbl Augenheilkd 226:459\u2013465","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","volume":"146","author":"Krohne","year":"2008","unstructured":"Krohne TU, Eter N, Holz FG, Meyer CH (2008) Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol 146:508\u2013512","journal-title":"Am J Ophthalmol"},{"key":"1959_CR13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"Lalwani","year":"2006","unstructured":"Lalwani GA, Rosenfeld PJ, Fung AE et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"1959_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","volume":"148","author":"Lalwani","year":"2009","unstructured":"Lalwani GA, Rosenfeld PJ, Fung AE et al (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148(1):43\u201358.e1","journal-title":"Am J Ophthalmol"},{"key":"1959_CR15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1055\/s-2008-1027636","volume":"225","author":"L\u00fcchtenberg","year":"2008","unstructured":"L\u00fcchtenberg M, Hoppe T, Ohrloff C et al (2008) Accessibility of information on eye diseases on the internet for the visually impaired user. Klin Monatsbl Augenheilkd 225:1075\u20131083","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000186499","volume":"223","author":"L\u00fcchtenberg","year":"2009","unstructured":"L\u00fcchtenberg M, Ohrloff C, Schalnus R (2009) Transparency of information on eye diseases on the internet. Ophthalmologica 223:145\u2013154","journal-title":"Ophthalmologica"},{"key":"1959_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00347-008-1702-6","volume":"105","author":"Meyer","year":"2008","unstructured":"Meyer CH, Helb HM, Eter N (2008) Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series. Ophthalmologe 105:125\u2013138","journal-title":"Ophthalmologe"},{"key":"1959_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-2008-1027475","volume":"225","author":"Meyer","year":"2008","unstructured":"Meyer CH, Holz FG (2008) Bonner record form: documentation of relevant parameters during intravitreal drug application. Klin Monatsbl Augenheilkd 225:629\u2013631","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000151246","volume":"222","author":"Meyer","year":"2008","unstructured":"Meyer CH, Lapolice DJ (2008) Computer-based visual evaluation as a screening tool after intravitreal injections of vascular endothelial growth factor inhibitors. Ophthalmologica 222:364\u2013368","journal-title":"Ophthalmologica"},{"key":"1959_CR20","unstructured":"Mitchell P, Korobelnik JF, Lanzetta P et al (2009) Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol May 20"},{"key":"1959_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","volume":"116","author":"Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD et al (2009) Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology 116:191\u2013199","journal-title":"Ophthalmology"},{"key":"1959_CR22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2008-1034969","volume":"213","author":"Radner","year":"1998","unstructured":"Radner W, Willinger U, Obermayer W et al (1998) Ein neuer Lesetest zur gleichzeitigen Untersuchung von Lesevisus und Lesegeschwindigkeit. Klin Monatsbl Augenheilkd 213:174\u2013181","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1959_CR23","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier J et al (2006) Ranibizumab for Neovascular Age-related Macular degeneration: Results of the MARINA Study. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"1959_CR24","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jcrs.2005.03.080","volume":"31","author":"Stifter","year":"2005","unstructured":"Stifter E, Weghaupt H, Benesch T et al (2005) Discriminative power of reading tests to differentiate visual impairment caused by cataract and age-related macular degeneration. J Cataract Refract Surg 31:2111\u20132119","journal-title":"J Cataract Refract Surg"},{"key":"1959_CR25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00347-009-1964-7","volume":"106","author":"Ziemssen","year":"2009","unstructured":"Ziemssen F, Wiedemann P, Kampik A et al (2009) Intravitreal injections of medications in Germany. Contract situation and legal conditions. Ophthalmologe 106:465\u2013470","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-1959-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-009-1959-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-1959-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:56Z","timestamp":1559037056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-009-1959-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1007\/s00347-009-1959-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}